Eagle Pharmaceuticals
EGRX
#10046
Rank
โ‚ฌ12.29 M
Marketcap
0,95ย โ‚ฌ
Share price
0.00%
Change (1 day)
-81.91%
Change (1 year)

Eagle Pharmaceuticals (EGRX) - Net assets

Net assets on the balance sheet as of June 2023 : โ‚ฌ0.23 Billion

According to Eagle Pharmaceuticals 's latest financial reports the company has โ‚ฌ0.23 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Eagle Pharmaceuticals - Net assets on balance sheet (from 2013 to 2023)

Net assets by year

Year Net assets Change
2022-12-31$โ‚ฌ0.21 B39.75%
2021-12-31$โ‚ฌ0.15 B3.03%
2020-12-31$โ‚ฌ0.15 B-5.45%
2019-12-31$โ‚ฌ0.15 B13.82%
2018-12-31$โ‚ฌ0.14 B-5.88%
2017-12-31$โ‚ฌ0.14 B3.85%
2016-12-31$โ‚ฌ0.14 B74%
2015-12-31$โ‚ฌ82.62 M
2014-09-30$โ‚ฌ26.07 M1613.45%
2013-09-30$โ‚ฌ1.52 M-116.18%
2012-09-30$-โ‚ฌ9.41 Million

Net assets for similar companies or competitors

Company Net assets differencediff. Country
โ‚ฌ65.84 B 28,264.55%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.12 B 6,415.51%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ40.64 B 17,407.54%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ5.26 B 2,169.48%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ5.41 B 2,231.77%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ13.14 B 5,562.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.09 B 6,402.14%๐Ÿ‡บ๐Ÿ‡ธ USA